Table 5.
Univariate | Multivariate | ||
---|---|---|---|
p-value | OR (95% CI) | p-value | |
Tumour stage | |||
T1 | 0,004 | 1.55 (1.17-2.04) | n.s. |
T2-4 | 1 | ||
Grading | |||
G1/2 | 0.003 | 1.61 (1.16-2.24) | n.s. |
G3 | 1 | ||
Lymphangiosis | |||
No | 0.001 | 1.72 (1.33-2.22) | n.s. |
Yes | 1 | ||
ER status | |||
Positive | 0.024 | 1.63 (1.03-2.59) | n.s. |
Negative | 1 | ||
PR status | |||
Positive | 0.014 | 1.54 (1.08-2.22) | n.s. |
Negative | 1 | ||
HER2 status | |||
Negative | 0.007 | 2.99 (1.067-8.36) | n.s. |
Positive | 1 | ||
Ki-67 | |||
≤14% | <0.001 | 1.76 (1.34-2.30) | n.s. |
>14% | 1 | ||
Size of nodal metastasis | |||
≤10 mm | <0.001 | 2.66 (1.81-3.91) | 0,001 |
>10 mm | 1 | ||
Nodal stage | |||
N1 | <0.001 | 1.96 (1.41-2.73) | n.s. |
N2-3 | 1 | ||
Capsular infiltration | |||
No | <0.001 | 2.22 (1.59-3.11) | n.s. |
Yes | 1 |
OR = Odds ratio; CI = confidence interval; n.s. = not significant.